Kim A. Johnson

METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS

Jie Ling, Kim A. Johnson, Zhuang Miao et al. · Drug Metabolism and Disposition · 2005 · 222 citations

Medicine, Pharmacokinetics, Pharmacology +14

Metabolism, Pharmacokinetics, and Excretion of a Highly Selective N-Methyl-d-aspartate Receptor Antagonist, Traxoprodil, in Human Cytochrome P450 2D6 Extensive and Poor Metabolizers

Kim A. Johnson, Ajit Shah, Sarah Jaw‐Tsai et al. · Drug Metabolism and Disposition · 2003 · 37 citations

Medicine, Pharmacokinetics, Pharmacology +14

Metabolism, Pharmacokinetics, and Excretion of a Cholesteryl Ester Transfer Protein Inhibitor, Torcetrapib, in Rats, Monkeys, and Mice: Characterization of Unusual and Novel Metabolites by High-Resolution Liquid Chromatography-Tandem Mass Spectrometry and 1H Nuclear Magnetic Resonance

Chandra Prakash, Weichao Chen, Michelle I. Rossulek et al. · Drug Metabolism and Disposition · 2008 · 36 citations

Medicine, Pharmacokinetics, Pharmacology +17

Inhibitors of HIV-1 attachment: The discovery and structure–activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophore

Jacob J. Swidorski, Zheng Liu, Zhiwei Yin et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 31 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Three-way data analysis of pollutant degradation profiles monitored using liquid chromatography-diode array detection

Kim A. Johnson, Anna de Juan, Sarah C. Rutan · Journal of Chemometrics · 1999 · 27 citations

Natural Sciences, Toxicology, Analytical Chemistry +16